Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hotez

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|April 18, 2023
Vaccines and therapeutics for immunocompromised patients with COVID-19Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
Plos Neglected Tropical Diseases|September 12, 2022
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c miceVictor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, et al.
Infection and Immunity|February 11, 2010
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanusBin Zhan, Samirah Perally, Peter M Brophy, et al.
Gates Open Research|September 21, 2018
Slaying little dragons: the impact of the Guinea Worm Eradication Program on dracunculiasis disability averted from 1990 to 2016Elizabeth A Cromwell, Sharon Roy, Dieudonne P Sankara, et al.
Plos Neglected Tropical Diseases|May 3, 2017
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Eclinicalmedicine|January 15, 2025
Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysisAnis Rassi, Alyssa Grimshaw, Ashwin Sarwal, et al.
Vaccine|July 21, 2023
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasisMarianna de Carvalho Clímaco, Luiza Almeida de Figueiredo, Rayane Cristina Lucas, et al.
The Lancet Regional Health. Europe|July 1, 2026
Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness AgendaMarion Koopmans, Christian Brechot, Roberto Bruzzone, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|April 18, 2023
Vaccines and therapeutics for immunocompromised patients with COVID-19Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
Plos Neglected Tropical Diseases|September 12, 2022
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c miceVictor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, et al.
Infection and Immunity|February 11, 2010
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanusBin Zhan, Samirah Perally, Peter M Brophy, et al.
Gates Open Research|September 21, 2018
Slaying little dragons: the impact of the Guinea Worm Eradication Program on dracunculiasis disability averted from 1990 to 2016Elizabeth A Cromwell, Sharon Roy, Dieudonne P Sankara, et al.
Plos Neglected Tropical Diseases|May 3, 2017
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adultsDavid J Diemert, Janaína Freire, Vanderson Valente, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Eclinicalmedicine|January 15, 2025
Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysisAnis Rassi, Alyssa Grimshaw, Ashwin Sarwal, et al.
Vaccine|July 21, 2023
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasisMarianna de Carvalho Clímaco, Luiza Almeida de Figueiredo, Rayane Cristina Lucas, et al.
The Lancet Regional Health. Europe|July 1, 2026
Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness AgendaMarion Koopmans, Christian Brechot, Roberto Bruzzone, et al.
Pageof 8